by Erin | Jul 17, 2026 | Blog
When Colorado defended its proposed price cap on Enbrel in federal court, it didn’t deny that someone would take a financial hit. It simply argued the hit didn’t have to land on the plaintiff in the case, the manufacturer. On July 1, 2026, a federal judge...
by Erin | Feb 18, 2026 | Blog
Polling by the Value of Care Coalition shows that when it comes to decisions about their health care, patients trust doctors (82%) — not government boards and panels (1%). If an option were included for “government officials in foreign countries,” it’s not hard to...
by Erin | Oct 22, 2025 | Blog
As states authorize and implement Prescription Drug Affordability Boards, health care stakeholders have raised concerns about both their decision-making processes and the potential negative consequences of those decisions. PDABs are inherently state-based...
by Erin | Sep 10, 2025 | Blog
Everyone knows you can’t compare apples and oranges. Yet that’s exactly what prescription drug affordability boards do when they make decisions about value. Now, a new video from the Value of Care Coalition outlines how this one-size-fits-all approach ignores clinical...
